Clinical Trial Associate
Alto Neuroscience
Clinical Trial Associate
Alto Neuroscience
AI-driven precision psychiatric drug development
About Alto Neuroscience, Inc.
At Alto Neuroscience, you will play a pivotal role in advancing precision psychiatry and improving how mental health disorders are treated. Join us in building the next generation of personalized neuroscience-based therapeutics.
Primary Role
The Clinical Trial Associate (CTA) position is responsible for the support of the study team by creating, distributing, maintaining, and organizing study materials, tools and documents to ensure conduct of clinical trials is in compliance with protocol requirements, SOPs and ICH GCP Guidelines. Additional responsibilities include general administrative support to the Clinical Operations Department.
What you'll do
Location
In office, Mountain View, CA
Salary Range
$80,000 to $95,000
*depending on qualifications and experience level
Travel Required
Qualifications
Required Skills:
Preferred Skills:
Physical Demands & Work Environment:
Alto Neuroscience is an equal-opportunity employer that does not discriminate on the basis of sex, age, race, color, religion, marital status, sexual orientation, gender identity, pregnancy, disability, or any other characteristic protected by law. We offer a welcoming and inclusive environment in service to one another, our products, the diverse consumers we represent, and the communities we call home. We do all of this with kindness, empathy and respect for each other. The above is intended to describe the general content of and requirements for the performance of this job. It should not be construed as an exhaustive statement of duties, responsibilities or physical requirements.
[]
AI-driven precision psychiatric drug development
Alto Neuroscience develops AI-guided precision psychiatric drugs. It uses brain biomarkers and clinical data to match patients to specific Alto drug candidates. The approach aims to improve outcomes with personalized, biology-based selection and relies on ongoing clinical trials and regulatory approval. The business model centers on developing and commercializing these drugs for the psychiatric market once approved.
Explore more opportunities at Alto Neuroscience